Delivery Order 36F79724D0101-36C24926N0651
Award Date 8/10/26
Potential Completion Date 11/9/26
Potential Value $379K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lawrenceville, Lawrence Township, NJ 08648, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration awarded a delivery order contract to Bristol-Myers Squibb Company for the pharmaceutical product IDECABTAGENE VICLEUCEL INJ,SUSP (ABECMA). This order was issued under Bristol-Myers Squibb's Pharmaceuticals and Drugs Federal Supply Schedule contract, using a firm fixed price payment structure. The potential value of the order is $314,322.29, with a performance period running through April 5, 2024. No set-aside designation was...
- This is a delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Bristol-Myers Squibb Company for the provision of ABECMA, a chimeric antigen receptor (CAR) T cell therapy, for use in transplant injections. The contract has a firm fixed price of $338,932.84 and an ultimate completion date of May 17, 2025. The contract is a task order under Bristol-Myers Squibb's $12.28 billion Federal Supply Schedule (FSS) contract with the VA, which covers a wide range of drugs,...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Bristol-Myers Squibb Company for the provision of ABECMA, a chimeric antigen receptor (CAR) T cell therapy, for use in transplant procedures. The order, worth $338,932.84, is part of a larger multiple-award Federal Supply Schedule (FSS) contract between the VA and Bristol-Myers Squibb, which has a ceiling value of $12,278,876,570.00 and runs through April 2029. This FSS contract covers a broad range...
- This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) to Bristol-Myers Squibb Company, a global biopharmaceutical manufacturer. The contract, valued at $338,932.84, is for the supply of ABECMA INJECTION, a chimeric antigen receptor (CAR) T cell therapy used for the treatment of certain types of cancer, including non-Hodgkin lymphoma and multiple myeloma. The contract supports the VA's Veterans Health Administration in providing advanced medical...
- This is a delivery order awarded by the Department of Veterans Affairs (VA) to Bristol-Myers Squibb Company, a global biopharmaceutical firm, for the provision of ABECMA injections. The firm fixed-price contract has a ceiling value of $338,932.84 and an ultimate completion date of August 15, 2025. The contract is not designated with any set-aside provisions. Bristol-Myers Squibb Company holds a significant Federal Supply Schedule (FSS) contract (ID: 36F79724D0101) with the VA, which has a...
- This is a federal contract award to Bristol-Myers Squibb Company, doing business as Bristol-Myers Squibb, for the delivery of the ABECMA chimeric antigen receptor (CAR) T cell immunotherapy. The award, valued at $314,322.29, is a delivery order placed against Bristol-Myers Squibb's existing Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs Veterans Health Administration (VA VHA). This multiple award FSS contract has a ceiling value of $12,278,876,570.00 and runs...
- Bristol-Myers Squibb Company was awarded a $314,322.29 delivery order for emergency pharmaceutical ABECMA CAR T cell therapy under the Pharmaceuticals and Drugs Federal Supply Schedule contract. The delivery order was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 to provide the BCMA-directed CAR T immunotherapy to support TVHS programs. Work will be performed by Bristol-Myers Squibb in Lawrenceville, New Jersey through March...
- This is a delivery order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Bristol-Myers Squibb Company, a global biopharmaceutical company. The contract is for the provision of ABECMA, a B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T immunotherapy. The delivery order has a ceiling value of $314,322.29 and is a firm fixed price contract with a period of performance from June 10, 2024 to July 9, 2024. The work will be performed...
- Veterans Integrated Service Network 9 issued a $364,139.25 delivery order to Bristol-Myers Squibb Company on June 18, 2026, for BREYANZI (lisocabtagene maraleucel) CAR T cell therapy under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The order is priced firm fixed price with no set-aside. Place of performance is Lawrenceville, New Jersey. The order is due for completion on September 17, 2026. The parent FSS vehicle, Pharmaceuticals and Drugs (FSS-61-IB), is a...
- Veterans Integrated Service Network 9 issued a $364,139.25 delivery order to Bristol-Myers Squibb Company on June 11, 2026, for BREYANZI CAT-T transplant therapy, with final completion scheduled for September 1, 2026. The order is issued under Bristol-Myers Squibb's Federal Supply Schedule contract (36F79724D0101) covering Pharmaceuticals and Drugs (FSS-61-IB), a multiple-award indefinite delivery/indefinite quantity vehicle with a $12.278 billion ceiling extending through April 30, 2029....